NCAM1 and melanoma: As expected, the expression of NLRC5 in various cancers24 and in this melanoma cohort was also correlated with the expression level of markers for CD8+ T cell activation, CD8A and granzyme A (GZMA)/perforin (PRF1), but not CD56, a marker for NK cells (Fig. S1).